Submitted EUA for COVID ARDS on June 7th sixty day approval window close. UK and EU interested in treatment. Potentially taking them from millions in revenue to billions. Worth the risk?
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.